# AnaptysBio, Inc. (ANAB)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ANAB/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 25.56M | $ -52.88M | $ -25.94M | $ 277.36M | $ 12.75M |
| 2025 | $ 240.21M | $ -13.55M | $ 20.08M | $ 290.64M | $ 37.21M |
| 2024 | $ 95.94M | $ -152.65M | $ -142.63M | N/A | $ 70.87M |
| 2023 | $ 18.55M | $ -176.91M | $ -131.49M | $ 17.81M | $ 88.10M |
| 2022 | $ 11.49M | $ -143.80M | $ -82.61M | $ 19.45M | $ 262.10M |
| 2021 | $ 75.09M | $ -68.70M | $ -56.21M | $ 20.96M | $ 356.43M |
| 2020 | $ 95.54M | $ -25.39M | $ -18.76M | $ 342.0K | $ 396.73M |
| 2019 | $ 10.33M | $ -125.64M | $ -90.77M | $ 2.90M | $ 405.01M |
| 2018 | $ 6.60M | $ -81.43M | $ -65.47M | $ 8.26M | $ 486.37M |
| 2017 | $ 13.47M | $ -40.51M | $ -26.58M | $ 14.45M | $ 307.58M |
| 2016 | $ 22.95M | $ -3.89M | $ -12.49M | $ 13.81M | $ 39.27M |
| 2015 | $ 24.67M | $ -7.59M | $ -13.91M | $ 4.92M | $ 42.34M |
| 2014 | $ 22.38M | $ 4.99M | $ 20.43M | $ 4.92M | $ 5.99M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 21.76 |
| Liabilities / Eq | 24.86 |
| Current Ratio | 7.58 |

## Other views

- [Metrics](https://sponda.capital/en/ANAB.md)
- [Charts](https://sponda.capital/en/ANAB/charts.md)
- [Compare](https://sponda.capital/en/ANAB/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.